World Generic Medicines Congress 2016

The benefits of generics medicines are well celebrated and demand will remain strong with escalating healthcare costs. However, generic pharmaceuticals will have to continue to overcome barriers including increasing competition, the innovator pipeline crisis and pricing pressure. In the rapidly changing market it is critical to adopt the right business strategy. 
The 10th Annual World Generic Medicines Congress is Europe’s premier business event providing a comprehensive review of affordable medicine business strategy. It unites senior executives from the generic and biosimilar industries to provide fresh insights, future market trends, innovative commercial strategies and opportunities for growth for affordable medicines

Exhibit

Symposia

Workshops

Organiser

Sponsor



The 10th World Generic Medicines Congress is the leading generic strategy conference in Europe. Increase your brand awareness and demonstrate thought leadership in front of over 150 senior representatives from generic pharmaceutical companies.

Your opportunity
• Grow long term relationships by arranging meetings with top prospects
• Speak and demonstrate thought leadership
• Increase brand awareness and positioning

Why sponsor
• Generate new business leads and develop relationships
• Build brand presence and raise brand profile
• Showcase latest products and innovations to prospective buyers
• Promote new services to prequalified clientele
• Meet new business partners and suppliers
• Educate pharma and biotech companies

Who will you meet
• Board level and senior representatives from generic pharmaceutical companies
• Investment banks
• Law firms

10 Reasons to Attend
  1. Identify where the generics industry growth opportunities are
  2. Gain an investor’s perspective on the generics market and understand what this means for your business
  3. Hear the latest legal and regulatory developments that will shape your strategy decisions
  4. Explore the growth opportunities of complex generics to strengthen business models
  5. Understand the current market trends and future challenges for biosimilar success
  6. Learn the impact of the current EU & US health policy environment on generic medicines
  7. Interact, debate and discuss the key topics of the generics and biosimilar industry at peer-to-peer roundtable discussions
  8. Discover untapped opportunities in the global market
  9. Collocated with create your own agenda and attend focussed sessions most relevant to your business needs
  10. Network with pioneers, influencers and innovators and return to your company with new ideas and relationships

.

.

Booking code
BR03


Package

Before 22nd January 2016

Full price

2 Day conference

£1,495

£1,595


To Register Click Here

World Generic Medicines Congress day 1


08:00

Registration


Generics and Biosimilars Commercial Strategy

08:50

Opening remarks from the chair

09:00

Generics market focus

Tommy Erdei, Global Joint Head of Pharmaceuticals and Life Sciences, Joint Head of European Healthcare Investment Banking,, Jefferies Group

09:30

Successful strategies to build new business, open up new markets and grow market share in MENA

Mazen S Darwazeh, Vice Chairman President & CEO MENA & Emerging Markets, Hikma Pharmaceuticals

10:00

The future of the biosimilar industry - mapping the evolution and development of the biosimilar sector

Mr Sandeep Athalye, Vice President and Head CDMA, Biosimilars, Boehringer Ingelheim

Mr Bruce Lott, Vice President of State Government Relations, Mylan Inc.

Dr Cyrus Karkaria, President - Biotechnology, Lupin Pharma

10:45

Speed networking

11:00

Morning refreshments

11:30

Biosimilars - A View From The Capital Markets

Mr Ashwin Pai, Senior Vice President Healthcare Investment Banking, Jefferies International

12:00

Government affairs affecting the US generics and Biosimilar market

Mr Bruce Lott, Vice President of State Government Relations, Mylan Inc.

12:30

Lunch

13:30

PEER TO PEER ROUNDTABLES

  • Implications of increasing pricing pressure regimes and required market strategies

  • Advantages of trade to the generic and biosimilar industry


  • Maximising growth opportunities to be gained from fast growing dynamic markets


  • What is a sustainable price for a generic and how do you go about achieving it?

  • Key Opinion Leader Perspectives and Impact on Adoption Rates for Biosimilars, Pricing Discounts & Rebates

  • Trends in Costs and Pricing


Generics

Afternoon Chair: Nitin Naik, Vice President-Global Life Sciences, Frost and Sullivan


15:00

Topic TBC

15:30

Afternoon refreshments

16:00

Role of R&D and niche area expertise

Dr Deepak Murpani, Global R&D Head, Polpharma

16:30

How smaller generic companies are competing in challenging EU countries

Ullrich Hanstein, General Manager, Help S.A.

17:00

Closing remarks from the chair

17:05

Drinks party


World Generic Medicines Congress day 2


08:00

Registration

08:50

Opening remarks from the chair

Mr Simon Cohen, Partner, Taylor Wessing


Generic Market Analysis

09:00

Current themes dominating US Generics

Ms Apurva Saraf, Vice President - Global Strategy and Corporate Development, Amneal

09:30

Value of Generic Medicines

Dr Pieter Dylst, Health Economics Officer, E.G.A. European Generic Medicines Association

10:00

The frenzy of M&A in Generics

Claudio Albrecht, Former CEO and Chairman of the Board of Directors, Actavis Group, Founder and Managing Partner, Albrecht, Prock & Partners AG

10:30

Strategic Marketing: Emerging versus mature markets

Mr Sameer Agarwal, Senior Vice President-Portfolio & Marketing, Mature & Emerging Markets, Frenesius Kabi

11:00

Morning refreshments


Payer Power

11:30

Purchasing power: how to influence purchasing decisions

Evert Jan van Lente, Director of EU Affairs, AOK Bundesverdand

12:00

An Industry Observer's Perspective on Cost Containment and Procurement of Generics

Mr Peter Wittner, Senior Consultant, Interpharm Consultancy

12:30

PANEL DISCUSSION: Trends in pricing and profits

Frances Cloud, Founder, Pharmacloud Ltd

Evert Jan van Lente, Director of EU Affairs, AOK Bundesverdand

Mr Peter Wittner, Senior Consultant, Interpharm Consultancy

13:30

Lunch

14:30

Legal and IP strategies for the generic medicines

Saufung Ma, Senior Associate, Taylor Wessing

Mr Simon Cohen, Partner, Taylor Wessing

15:00

Advantages of Trade Policy to the generic and biosimilar industry

Mr David Jauch, Global Regulatory Affairs and Government Relations Manager, Fresenius Kabi

15:30

Afternoon refreshments

16:00

Updates on health policies

Juliana Reed, Vice President, Government Affairs, Hospira

16:30

Generics product development from a CDMO perspective

Reserved for GB Patent

Mr Antonio Lopez, Director of Business Management for Spain, Portugal and France, Recipharm

Amine Tahiri, Sales Director South EU, Development & technology, Recipharm

17:00

Closing remarks from the chair




More events

BIO International Convention (BIO) 2021

Thu, 10 Jun 2021 - Fri, 18 Jun 2021

PMWC 2021 Virtual

Mon, 14 Jun 2021 - Fri, 18 Jun 2021

STI & HIV 2021 World Congress

Mon, 14 Jun 2021 - Sat, 17 Jul 2021

40th Annual Meeting of the German Society of Senology

Thu, 17 Jun 2021 - Sat, 19 Jun 2021


Messegelände
München, 81823
Germany
ASM Microbe 2021

Sun, 20 Jun 2021 - Thu, 24 Jun 2021

Arab Health Exhibition 2021

Mon, 21 Jun 2021 - Thu, 24 Jun 2021


Sheikh Zayed Rd
Dubai, 9292
United Arab Emirates
MEDLAB Middle East Exhibition and Congress 2021

Mon, 21 Jun 2021 - Thu, 24 Jun 2021


Sheikh Zayed Rd
Dubai, 9292
United Arab Emirates
Cannes Lions

Mon, 21 Jun 2021 - Fri, 25 Jun 2021

International Forum on Advancements in Healthcare 2021

Wed, 23 Jun 2021 - Fri, 25 Jun 2021


South Las Vegas Boulevard 3799
Las Vegas, Nevada 89109
United States
Austrian Health Forum 2021

Thu, 24 Jun 2021 - Sat, 26 Jun 2021

37th Annual Meeting ESHRE 2021

Sat, 26 Jun 2021 - Thu, 1 Jul 2021

Synergy Masterclass 2021

Sat, 26 Jun 2021 - Sat, 26 Jun 2021

Related articles